NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000251493.2 | forkhead box D1 | |
ENSG00000150907.6 | forkhead box O1 | |
ENSG00000204060.4 | forkhead box O6 | |
ENSG00000176165.7 | forkhead box G1 | |
ENSG00000114861.14 | forkhead box P1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXO1 | hg19_v2_chr13_-_41240717_41240735 | 0.75 | 8.8e-02 | Click! |
FOXD1 | hg19_v2_chr5_-_72744336_72744359 | 0.74 | 9.1e-02 | Click! |
FOXP1 | hg19_v2_chr3_-_71353892_71353928 | -0.53 | 2.8e-01 | Click! |
FOXO6 | hg19_v2_chr1_+_41827594_41827594 | 0.40 | 4.3e-01 | Click! |
FOXG1 | hg19_v2_chr14_+_29236269_29236287 | -0.15 | 7.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_178865747 Show fit | 0.86 |
ENST00000435560.1
|
RP11-360P21.2 |
|
chr14_-_54418598 Show fit | 0.81 |
ENST00000609748.1
ENST00000558961.1 |
bone morphogenetic protein 4 |
|
chr7_-_95225768 Show fit | 0.80 |
ENST00000005178.5
|
pyruvate dehydrogenase kinase, isozyme 4 |
|
chr5_-_42811986 Show fit | 0.70 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
selenoprotein P, plasma, 1 |
|
chr17_-_8263538 Show fit | 0.69 |
ENST00000535173.1
|
HCG1985372; Uncharacterized protein; cDNA FLJ37541 fis, clone BRCAN2026340 |
|
chr19_+_12902289 Show fit | 0.60 |
ENST00000302754.4
|
jun B proto-oncogene |
|
chr17_+_37821593 Show fit | 0.58 |
ENST00000578283.1
|
titin-cap |
|
chrX_-_55208866 Show fit | 0.58 |
ENST00000545075.1
|
MT-RNR2-like 10 |
|
chr7_-_84122033 Show fit | 0.58 |
ENST00000424555.1
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
|
chr5_-_42812143 Show fit | 0.57 |
ENST00000514985.1
|
selenoprotein P, plasma, 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.9 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.9 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.8 | GO:0061155 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.0 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.7 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.2 | 0.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.5 | GO:0031673 | H zone(GO:0031673) |
0.0 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.8 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |